Literature DB >> 9705255

Transcription of Epstein-Barr virus latent cycle genes in oral hairy leukoplakia.

J Webster-Cyriaque1, N Raab-Traub.   

Abstract

The hairy leukoplakia lesion (HLP) is a unique example of a permissive infection with Epstein-Barr virus (EBV) in the tongue epithelium. HLP contains abundant replicating viral DNA and may be coinfected with multiple EBV strains. In this study, characterization of viral gene transcription within HLP biopsy specimens revealed that several genes, usually expressed in latently infected lymphocytes, are also transcribed in the HLP lesion. The BamHI W and C promoters, (Wp and Cp) are consistently active in the HLP lesion, resulting in transcription and processing of mRNAs that encode the Epstein-Barr nuclear antigens (EBNAs) EBNA-LP, EBNA1, EBNA2, EBNA3B, and EBNA3C. The EBNA2 protein has been shown to activate expression of the EBV receptor, CD21. In HLP, CD21 transcription is also detected, usually in samples that contain transcripts for EBNA2. Transcripts encoding the LMP1 gene, the LMP2 gene, and rightward transcripts from the BamHI A fragment of the EBV genome are also detected in HLP. These gene products are invariably expressed in latently infected lymphocytes. This pattern of transcription suggests that genes characteristic of latent infection are also expressed in HLP. The activation of Wp and expression of EBNA2 and CD21 may contribute to the unique ability of the HLP lesion to permit superinfection and viral replication of multiple EBV strains. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9705255     DOI: 10.1006/viro.1998.9268

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  20 in total

1.  Requirement for cell-to-cell contact in Epstein-Barr virus infection of nasopharyngeal carcinoma cells and keratinocytes.

Authors:  Y Chang; C H Tung; Y T Huang; J Lu; J Y Chen; C H Tsai
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

2.  Virus and cell RNAs expressed during Epstein-Barr virus replication.

Authors:  Jing Yuan; Ellen Cahir-McFarland; Bo Zhao; Elliott Kieff
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

Review 3.  Epstein-Barr virus in the pathogenesis of oral cancers.

Authors:  J T Guidry; C E Birdwell; R S Scott
Journal:  Oral Dis       Date:  2017-04-18       Impact factor: 3.511

4.  Epstein-Barr virus lytic infection contributes to lymphoproliferative disease in a SCID mouse model.

Authors:  Gregory K Hong; Margaret L Gulley; Wen-Hai Feng; Henri-Jacques Delecluse; Elizabeth Holley-Guthrie; Shannon C Kenney
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

5.  Interferon regulatory factor 7 is negatively regulated by the Epstein-Barr virus immediate-early gene, BZLF-1.

Authors:  Angela M Hahn; Leslie E Huye; Shunbin Ning; Jennifer Webster-Cyriaque; Joseph S Pagano
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

6.  Hairy leukoplakia: an unusual combination of transforming and permissive Epstein-Barr virus infections.

Authors:  J Webster-Cyriaque; J Middeldorp; N Raab-Traub
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

7.  Epstein-Barr virus BamHi-a rightward transcript-encoded RPMS protein interacts with the CBF1-associated corepressor CIR to negatively regulate the activity of EBNA2 and NotchIC.

Authors:  J Zhang; H Chen; G Weinmaster; S D Hayward
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

8.  Epithelial cell adhesion to extracellular matrix proteins induces tyrosine phosphorylation of the Epstein-Barr virus latent membrane protein 2: a role for C-terminal Src kinase.

Authors:  F Scholle; R Longnecker; N Raab-Traub
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

9.  The C-mer gene is induced by Epstein-Barr virus immediate-early protein BRLF1.

Authors:  Yuling Li; Nupam P Mahajan; Jennifer Webster-Cyriaque; Prasanna Bhende; Gregory K Hong; H Shelton Earp; Shannon Kenney
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

10.  Identification and characterization of the conserved nucleoside-binding sites in the Epstein-Barr virus thymidine kinase.

Authors:  Chung-Chun Wu; Min-Che Chen; Ya-Ru Chang; Tsuey-Ying Hsu; Jen-Yang Chen
Journal:  Biochem J       Date:  2004-05-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.